Traditional phosphotyrosine antibodies miss rare, low-abundance phosphorylation events — sometimes up to 90% of them. AxoBind SureCapture-pY changes the game with proprietary superbinder technology, delivering unmatched affinity and specificity for the deepest phosphoproteome coverage ever reported.
Sold out
